Clinical Trial

Safety and Efficacy Study of Collagenase CNT201 Injection for Treatment of Dupuytren's Contracture

Name: Safety and Efficacy Study of Collagenase CNT201 Injection for Treatment of Dupuytren's Contracture — clinical trial record (NCT07640425)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This trial is a multicenter, Phase 1/2, study to assess the safety, tolerability, efficacy, PK, and immunogenicity of CNT201 in adult participants with DC (Dupuytren's Contracture).

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-06-05.

Trial Details

NCT Number	NCT07640425
Lead Sponsor	CONNEXT
Conditions	Dupuytren Contracture, Dupuytren Disease of Finger
Enrollment	60 participants
Start Date	2024-07-23
Primary Completion	2027-07-01 (estimated)
Study Completion	2027-07-25 (estimated)
Updated on ClinicalTrials.gov	2026-06-12